1.	Phase III Placebo-Controlled Study of Soy Phytoestrogens in the Management of Hot Flashes in Women with a History of Breast Cancer (Summary Last Modified 08/98) Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-969258, NCI-P97-0126
2.	Phase III Randomized Study of Isoflavones in Reducing Risk Factors in Patients With Stage I or II Prostate Cancer Phase: Phase III Type: Prevention Status: Completed Age: 50 to 80 Sponsor: NCI Protocol IDs: MCC-0002, NCI-4031, NCI-P01-0195, NCT00027950
3.	Phase III Randomized Study of the Effects of Dietary Soy on Estrogens in Breast Fluid, Serum, and Urine Samples From Healthy Women Phase: Phase III Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 30 to 45 Sponsor: NCI Protocol IDs: UHM-CHS-4116, CHS 14116, NCT00513916
4.	Phase II Randomized Study of Soy Isoflavones Before Radical Prostatectomy in Patients With Stage I or II Adenocarcinoma of the Prostate Phase: Phase II Type: Prevention, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: WSU-C-2418, NCT00078923
5.	Phase II Randomized Study of Neoadjuvant Dietary Supplementation With Soy in Patients Undergoing Radical Prostatectomy for Localized Prostate Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: Over 18 Sponsor: NCI Protocol IDs: CCCWFU-98203, CCCWFU-98203, CCCWFU-BG03-332, NCT00345813
6.	The Specific Role of Isoflavones in Reducing Prostate Cancer Risk Phase: Phase II Type: Treatment Status: Closed Age: 50 to 80 Sponsor: Other Protocol IDs: MCC-12835, NCI #4031, CA 81920, NCT00617617
7.	Study of Metabolic Fate and Plasma Kinetics of Dietary Soy Isoflavones (Summary Last Modified 06/2000) Phase: No phase specified Type: Prevention Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UCMC-CHMC-91-5-3, NCI-P97-0117, NCT00003100
8.	Randomized Pilot Study of Isoflavones Versus Lycopene Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 45 to 80 Sponsor: NCI Protocol IDs: MCC-0105, NCI-3811, NCI-P02-0216, HLMCC 0105, NCT00042731
9.	Pilot Study of Soy-Based Meal Replacement (Almased®) as a Weight Loss Intervention in Patients With Estrogen Receptor/Progesterone Receptor-Negative Stage I-III Breast Cancer in Complete Remission Phase: No phase specified Type: Behavioral study, Educational/Counseling/Training, Supportive care Status: Closed Age: 21 and over Sponsor: NCI Protocol IDs: CCCWFU-98904, NCT00343434
10.	Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance Phase: No phase specified Type: Treatment Status: Closed Age: 45 and over Sponsor: Other Protocol IDs: PROS0022, 97408, NCT00482157, PROS0022, NCT00482157
11.	Soy, Selenium and Breast Cancer Risk Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Completed Age: 35 to 50 Sponsor: Other Protocol IDs: R14697, 07/Q0101/10, NCT00555386